$RLFTF GENEVA, SWITZERLAND / ACCESSWIRE / May 28,
Post# of 653
(Total Views: 240)
Posted On: 05/28/2021 3:02:27 AM
$RLFTF GENEVA, SWITZERLAND / ACCESSWIRE / May 28, 2021 /RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"
, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat COVID-19 induced respiratory disorders, today announced the appointment of Taneli Jouhikainen, M.D., MBA, to the newly created position of Chief Operating Officer (COO), effective June 1, 2021.
http://crweworld.com/article/news-provided-by...ng-officer
, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat COVID-19 induced respiratory disorders, today announced the appointment of Taneli Jouhikainen, M.D., MBA, to the newly created position of Chief Operating Officer (COO), effective June 1, 2021. http://crweworld.com/article/news-provided-by...ng-officer
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
Scroll down for more posts ▼